好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Headache and Pain: Triptan Mechanisms - Thalamic and Trigeminal Modulation

Thursday 04/29/04
03:45 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Headache and Pain
No CME available
Event Timeline
03:45 PM - 05:00 PM Abstract 001 - Intravenous Administration of the Serotonin (5HT) [sub]1B/D[/sub] Receptor Agonist Zolmitriptan Blocks Central Sensitization in the Trigeminal Nucleus Caudalis
03:45 PM - 05:00 PM Abstract 002 - True Nasopharyngeal Absorption of Zolmitriptan Following Administration of Zolmitriptan Nasal Spray
03:45 PM - 05:00 PM Abstract 003 - Estrogen Regulates Kinase Gene Expression in Trigeminal Neurons in Culture: Relevance to Menstrual Migraine
03:45 PM - 05:00 PM Abstract 004 - Propranolol Modulates Trigeminovascular Nociception in the Ventroposteromedial Nucleus (VPM) of the Rat Thalamus: A Possible Site of Action?
03:45 PM - 05:00 PM Abstract 005 - Serotonin Receptors Modulate Trigeminovascular Nociception in the Ventroposteromedial Nucleus (VPM) of the Thalamus: A Possible Site of Action of Triptans?
Faculty Disclosures
Gregory D. Cascino, MD, FAAN Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Thomas N. Ward, MD, FAAN No disclosure on file
A. M. Barrett, MD, FAAN The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD. Dr. Barrett has received personal compensation in the range of $10,000-$49,999 for serving as a scientific advisor with Winifred Masterson Burke Foundation.
Gregory A. Worrell, MD Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Maciej M. Mrugala, MD, PhD, MPH, FAAN Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Massimo Leone No disclosure on file
Ty Shang, MD No disclosure on file
No disclosure on file
Moshe A. Mizrahi, MD, FAAN Dr. Mizrahi has nothing to disclose.
Akanksha Sharma, MD Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Incyte. The institution of Dr. Sharma has received research support from Novocure. The institution of Dr. Sharma has received research support from Apollomics. The institution of Dr. Sharma has received research support from Curis. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with National Brain Tumor Society. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Mohamed A. Sarhan No disclosure on file
Jennifer Wax, MD No disclosure on file
Justin T. Low, MD, PhD Dr. Low has nothing to disclose.
Jonathan D. Thomas, MD No disclosure on file
Meghan D. Caulfield, PhD No disclosure on file
Khalil Husari, MD The institution of Dr. Husari has received research support from Maryland Innovation Initiative.
Peter Sguigna, MD Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
Jean Khoury, MD Dr. Khoury has nothing to disclose.